Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01792063
Other study ID # 43430
Secondary ID
Status Completed
Phase Phase 4
First received February 12, 2013
Last updated April 18, 2013
Start date February 2013
Est. completion date April 2013

Study information

Verified date April 2013
Source Istanbul University
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug AdministrationTurkey: Ethics Committee
Study type Interventional

Clinical Trial Summary

In our study we aim to study the effects of two preparations of Sevoflurane in vital capacity rapid inhalation induction.


Recruitment information / eligibility

Status Completed
Enrollment 200
Est. completion date April 2013
Est. primary completion date April 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Patients undergoing abdominal surgery

Exclusion Criteria:

- Patients with any cardiovascular or respiratory disease, usage of any kind of sedative drug, expected airway difficulty and obese patients (BMI>35) will be excluded from the study

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention


Intervention

Drug:
Sevoflurane

Sevoflurane


Locations

Country Name City State
Turkey Cerrahpasa Medical Faculty Anesthesiology and Reanimation Department Istanbul Fatih

Sponsors (1)

Lead Sponsor Collaborator
Istanbul University

Country where clinical trial is conducted

Turkey, 

References & Publications (1)

Baker MT. Sevoflurane: are there differences in products? Anesth Analg. 2007 Jun;104(6):1447-51, table of contents. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary effect of different preparations of sevoflurane on Induction on hypnosis time Induction for anesthesia will be achieved with sevoflurane A and Sevoflurane B in total of 100 randomized (American Society of Anesthesiology status I-II) patients undergoing abdominal surgery. During the induction patients will be asked to breath as deep as possible and then hold their breaths to the point where they cannot anymore and flexing their right arm. Occurrence of hypnosis will be confirmed with both the loss of eyelash-reflex and failing of flexed-holding arm. Time and number of breaths needed for the loss of consciousness will be noted. Existence of hiccup, cough, increase in secretions, and refusal of the mask by the patient will be reported if any. All patients will be extubated and released to the ward after they are questioned about any discomfort or issue they want to report to anesthesiologist 1 hour No
Secondary effect of different sevoflurane preparations on hemodynamics After the induction and occurrence of hypnosis, Systemic arterial pressure (SAP) values will be noted. Tracheal intubation will be performed and post-intubation SAP values will be noted. The SAP values will noted in the 5th minute of the induction. 1 hour No
See also
  Status Clinical Trial Phase
Recruiting NCT05819996 - Addressing Tetrachloroethylene Exposure in an Impacted Community N/A